Publish date:

Precision Castparts Joins S&P 500

It's replacing MedImmune.
Author:

Standard & Poor's said

Precision Castparts

(PCP)

will replace

MedImmune

(MEDI)

in the

S&P 500

after the close of trading.

The change is being made because MedImmune is about to be acquired by

TST Recommends

AstraZeneca

(AZN) - Get Report

. S&P 500 constituent

Apple

(AAPL) - Get Report

will take MedImmune's place in the S&P 100.

Precision Castparts, a maker of components for industrial turbines and aerospace applications, was part of the S&P MidCap 400. Taking its slot in that index is

Endo Pharmaceuticals

(ENDP) - Get Report

.